|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-2-6
|
|
pubmed:abstractText |
Older patients, even if fit, are often considered incapable of tolerating platinum-based systemic therapy. We performed a retrospective analysis of Eastern Cooperative Oncology Group (ECOG) 5592, a phase III randomized trial of platinum-based chemotherapy regimens for non-small-cell lung cancer (NSCLC), and compared outcomes in enrollees 70 years of age and older with those in younger patients.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
6
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
173-81
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11830607-Aged,
pubmed-meshheading:11830607-Aged, 80 and over,
pubmed-meshheading:11830607-Aging,
pubmed-meshheading:11830607-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11830607-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11830607-Cisplatin,
pubmed-meshheading:11830607-Etoposide,
pubmed-meshheading:11830607-Female,
pubmed-meshheading:11830607-Humans,
pubmed-meshheading:11830607-Lung Neoplasms,
pubmed-meshheading:11830607-Male,
pubmed-meshheading:11830607-Paclitaxel,
pubmed-meshheading:11830607-Quality of Life,
pubmed-meshheading:11830607-Random Allocation,
pubmed-meshheading:11830607-Retrospective Studies,
pubmed-meshheading:11830607-Survival Analysis,
pubmed-meshheading:11830607-Time Factors,
pubmed-meshheading:11830607-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
|
|
pubmed:affiliation |
C. J. Langer, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. CJ_Langer@fccc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
